Zoli Matteo, Mazzatenta Diego, Valluzzi Adelaide, Marucci Gianluca, Acciarri Nicola, Pasquini Ernesto, Frank Giorgio
Department of Neurosurgery, Center of Surgery for Pituitary Tumors and Endoscopic Skull Base Surgery, IRCCS Istituto delle Scienze Neurologiche, Bellaria Hospital, Bologna.
Neurosurg Focus. 2014;37(4):E11. doi: 10.3171/2014.7.FOCUS14317.
Object In the last decade the indications for the endoscopic endonasal approach have been progressively expanded to include lesions that have not been traditionally considered amenable to resection through the transsphenoidal route. In this study, the authors analyze their experience with hypothalamic gliomas treated via the endoscopic endonasal approach. Methods Consecutive cases of hypothalamic gliomas treated since 2007 via an endoscopic endonasal approach were reviewed. Preoperative and postoperative neuroimaging as well as endocrinological, neurological, and visual symptoms were analyzed to assess the surgical outcome. Signs and symptoms of hypothalamic dysfunction including body mass index (BMI), memory, sleep-wake rhythm, and polyphagia were prospectively collected pre- and postoperatively to assess hypothalamic function. Quality of life was evaluated using the Katz scale. Results In the initial phase the endoscopic endonasal approach was adopted in 3 cases with a palliative intent, to obtain a biopsy sample or for debulking of the mass followed by radio- or chemotherapy. In 2 later cases it was successfully adopted to achieve gross-total tumor resection. Complications consisted of 2 postoperative CSF leaks, which required an endoscopic endonasal reintervention. Visual deficit improved in 3 cases and normalized in the other 2. Four patients developed diabetes insipidus, and 3 an anterior panhypopituitarism. All patients had a moderate increase in BMI. No patients presented with any other signs of hypothalamic damage, and their quality of life at follow-up is normal. Conclusions Despite the limitations of a short follow-up and small sample, the authors' early experience with the endoscopic endonasal approach has revealed it to be a direct, straightforward, and safe approach to third ventricle astrocytomas. It allowed the authors to perform tumor resection with the same microsurgical technique: dissecting the tumor with 2 hands, performing a central debulking, and controlling the bleeding with bipolar coagulation. The main limitations were represented by some anatomical conditions, such as the position of the chiasm and the anterior communicating artery complex and, finally, by the challenge of watertight plastic repair. To definitively evaluate the role of this approach in hypothalamic gliomas, a comparison with transcranial series would be necessary, but due to the rarity of these cases such a study is still lacking. The authors observed that more aggressive surgery is associated with a worse endocrinological outcome; thus they consider it to be an open question (in particular in prepubertal patients) whether radical removal is an advisable goal for hypothalamic gliomas.
目的 在过去十年中,鼻内镜经鼻入路的适应证已逐步扩大,包括一些传统上认为不适合经蝶窦途径切除的病变。在本研究中,作者分析了他们采用鼻内镜经鼻入路治疗下丘脑胶质瘤的经验。方法 回顾自2007年以来采用鼻内镜经鼻入路治疗的连续性下丘脑胶质瘤病例。分析术前和术后神经影像学检查以及内分泌、神经和视觉症状,以评估手术效果。前瞻性收集术前和术后下丘脑功能障碍的体征和症状,包括体重指数(BMI)、记忆力、睡眠-觉醒节律和多食,以评估下丘脑功能。使用Katz量表评估生活质量。结果 在初始阶段,鼻内镜经鼻入路应用于3例患者,目的是姑息性治疗,获取活检样本或对肿块进行减瘤,随后进行放疗或化疗。在随后的2例患者中,成功采用该入路实现了肿瘤全切除。并发症包括2例术后脑脊液漏,需要鼻内镜经鼻再次干预。3例患者视力缺陷改善,另外2例恢复正常。4例患者发生尿崩症,3例发生垂体前叶功能减退。所有患者BMI均有适度增加。没有患者出现下丘脑损伤的其他任何体征,随访时他们的生活质量正常。结论 尽管随访时间短且样本量小存在局限性,但作者采用鼻内镜经鼻入路的早期经验表明,该入路对于第三脑室星形细胞瘤是一种直接、简便且安全的方法。它使作者能够采用与显微手术相同的技术进行肿瘤切除:双手分离肿瘤、进行中央减瘤以及用双极电凝控制出血。主要局限性表现为一些解剖学情况,如视交叉和前交通动脉复合体的位置,最后还有严密的整形修复的挑战。为了明确评估该入路在下丘脑胶质瘤中的作用,有必要与经颅手术系列进行比较,但由于这些病例罕见,此类研究仍然缺乏。作者观察到更积极的手术与更差的内分泌结果相关;因此他们认为对于下丘脑胶质瘤,彻底切除是否是一个可取的目标(特别是在青春期前患者中)仍是一个有待探讨的问题。